Armistice Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Armistice Capital’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,890,000	Closed	-$4.25M	–	300
2023 Q2	$4.25M	Buy	+4,890,000	New	+$3.49M	0.06%	121

Armistice Capital's SURF Position: Q3 2023 in Review

Armistice Capital sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 4,890,000 shares — an estimated $4.25M sold.

Armistice Capital first reported a position in SURF in Q2 2023 and held it in 1 quarter. The position peaked at $4.25M in Q2 2023. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Armistice Capital reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Armistice Capital sold 4,890,000 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $4.25M.
Armistice Capital first reported a position in Surface Oncology, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Armistice Capital's Surface Oncology, Inc. Common Stock position peaked at $4.25M in Q2 2023.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Armistice Capital's 13F filing for Q3 2023, filed 14 Nov 2023.